Steve Schonfeld’s BioNTech BNTX Stock Holding History

Steve Schonfeld’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,078	Closed	-$2.2M	–	2247
2025 Q4	$2.2M	Buy	+23,078	New	+$2.33M	0.01%	843
2024 Q1	–	Sell	-13,677	Closed	-$1.44M	–	2083
2023 Q4	$1.44M	Buy	13,677 +11,377	+495%	+$1.15M	0.01%	912
2023 Q3	$250K	Sell	2,300 -79,398	-97%	-$8.78M	﹤0.01%	1357
2023 Q2	$8.82M	Buy	+81,698	New	+$9.19M	0.08%	371
2023 Q1	–	Sell	-12,080	Closed	-$1.81M	–	2125
2022 Q4	$1.81M	Buy	+12,080	New	+$1.86M	0.02%	860
2022 Q3	–	Sell	-34,795	Closed	-$5.19M	–	2958
2022 Q2	$5.19M	Buy	+34,795	New	+$5.32M	0.05%	458
2022 Q1	–	Sell	-3,200	Closed	-$825K	–	2601
2021 Q4	$825K	Buy	+3,200	New	+$876K	0.01%	1025
2021 Q1	–	Sell	-11,900	Closed	-$970K	–	1810
2020 Q4	$970K	Sell	11,900 -8,916	-43%	-$875K	0.01%	827
2020 Q3	$1.44M	Sell	20,816 -33,784	-62%	-$2.42M	0.03%	606
2020 Q2	$3.64M	Buy	+54,600	New	+$2.73M	0.09%	281

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steve Schonfeld's BNTX Position: Q1 2026 in Review

Steve Schonfeld sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 23,078 shares — an estimated $2.2M sold.

Steve Schonfeld first reported a position in BNTX in Q2 2020 and held it in 10 quarters. The position peaked at $8.82M in Q2 2023. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Steve Schonfeld reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Steve Schonfeld sold 23,078 BioNTech shares in Q1 2026, an estimated $2.2M.
Steve Schonfeld first reported a position in BioNTech in Q2 2020 and held it in 10 quarters.
Steve Schonfeld's BioNTech position peaked at $8.82M in Q2 2023.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.